Diagnostics & Research
The Diagnostics & Research industry has a total of 45 stocks, with a combined market cap of $759.4 billion, total revenue of $168.76 billion and a weighted average PE ratio of 43.41.
Market Cap
759.4B
Revenue
168.76B
Profits
17.49B
PE Ratio
43.41
Profit Margin
10.37%
Dividend Yield
0.22%
45 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 198.93B | 0.23% | 2,108,183 | 45.20B |
| 2 | DHR | Danaher Corporation | 142.11B | 0.87% | 4,469,299 | 24.78B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 43.94B | 3.02% | 953,080 | 4.45B |
| 4 | NTRA | Natera, Inc. | 39.72B | 1.73% | 867,636 | 2.50B |
| 5 | A | Agilent Technologies, Inc. | 38.05B | -0.36% | 1,909,132 | 7.23B |
| 6 | WAT | Waters Corporation | 36.81B | -0.39% | 567,578 | 3.77B |
| 7 | IQV | IQVIA Holdings Inc. | 34.52B | -0.49% | 1,143,658 | 16.63B |
| 8 | ILMN | Illumina, Inc. | 28.32B | -2.12% | 1,782,355 | 4.39B |
| 9 | MTD | Mettler-Toledo International Inc. | 26.60B | 0.13% | 139,782 | 4.09B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.34B | -2.05% | 1,193,176 | 11.28B |
| 11 | LH | Labcorp Holdings Inc. | 22.30B | -1.34% | 809,582 | 14.14B |
| 12 | GH | Guardant Health, Inc. | 21.61B | 1.78% | 1,548,891 | 1.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.11B | -1.29% | 283,060 | 2.68B |
| 14 | ICLR | ICON Public Limited Company | 13.18B | 2.45% | 462,847 | 8.27B |
| 15 | RVTY | Revvity, Inc. | 12.42B | 0.13% | 834,156 | 2.90B |
| 16 | CRL | Charles River Laboratories International, Inc. | 10.99B | -1.29% | 860,627 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.53B | -0.77% | 3,273,899 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 5.97B | 4.01% | 683,239 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 5.77B | 0.09% | 1,195,004 | 409.48M |
| 20 | SHC | Sotera Health Company | 5.18B | 2.14% | 2,392,659 | 1.19B |
| 21 | RDNT | RadNet, Inc. | 4.83B | -2.18% | 848,148 | 2.14B |
| 22 | VCYT | Veracyte, Inc. | 4.75B | 5.10% | 908,829 | 541.74M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 3.67B | 6.86% | 3,986,034 | 295.41M |
| 24 | GRAL | GRAIL, Inc. | 3.19B | 1.70% | 539,805 | 156.12M |
| 25 | WGS | GeneDx Holdings Corp. | 1.96B | 5.94% | 763,791 | 442.68M |
| 26 | NEO | NeoGenomics, Inc. | 1.89B | 1.90% | 3,068,688 | 745.97M |
| 27 | PSNL | Personalis, Inc. | 1.65B | 5.06% | 5,009,789 | 64.52M |
| 28 | CDNA | CareDx, Inc. | 1.54B | 2.83% | 619,150 | 412.82M |
| 29 | OPK | OPKO Health, Inc. | 906.11M | -1.64% | 1,789,413 | 581.12M |
| 30 | CSTL | Castle Biosciences, Inc. | 728.53M | 3.89% | 189,144 | 339.92M |
| 31 | FLGT | Fulgent Genetics, Inc. | 596.70M | 2.69% | 192,180 | 320.35M |
| 32 | MYGN | Myriad Genetics, Inc. | 595.97M | 4.47% | 1,121,602 | 829.00M |
| 33 | BDSX | Biodesix, Inc. | 217.47M | -0.62% | 46,332 | 96.10M |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | 155.64M | 8.07% | 159,883 | 1.95M |
| 35 | XGN | Exagen Inc. | 103.89M | 5.13% | 169,682 | 68.38M |
| 36 | BNR | Burning Rock Biotech Limited | 98.08M | -6.44% | 15,410 | 74.58M |
| 37 | PRPO | Precipio, Inc. | 45.11M | 8.79% | 170,500 | 25.83M |
| 38 | MDXH | MDxHealth SA | 22.55M | 5.76% | 474,732 | 110.97M |
| 39 | QUCY | Quantum Cyber N.V. | 18.03M | -2.38% | 472,010 | 537.08K |
| 40 | XWEL | XWELL, Inc. | 9.12M | 13.70% | 150,345 | 28.83M |
| 41 | ADVB | Advanced Biomed Inc. | 8.59M | 2.16% | 3,108 | - |
| 42 | MBAI | Check-Cap Ltd. | 7.36M | -10.62% | 99,649 | - |
| 43 | NDRA | ENDRA Life Sciences Inc. | 7.13M | 1.26% | 18,255 | - |
| 44 | BIAF | bioAffinity Technologies, Inc. | 3.27M | 1.83% | 93,710 | 5.66M |
| 45 | ISPC | iSpecimen Inc. | 3.20M | -6.69% | 742,127 | 1.03M |